HyBryte Shows Promise for Early-Stage CTCL

782 words (source) vs. 472 words (mine) - 1% match Some rare diseases or rare cancers are exceedingly difficult to treat. For example, for patients with early-stage cutaneous T-cell lymphoma…

Continue Reading HyBryte Shows Promise for Early-Stage CTCL

ALXN1840 Shows Promise for Wilson Disease

Clinical trials can be beneficial for finding and evaluating new treatment options. Recently, biopharmaceutical company AstraZeneca shared how ALXN1840, a potential treatment for patients with Wilson disease, reached its primary…

Continue Reading ALXN1840 Shows Promise for Wilson Disease